| scholarly article | Q13442814 |
| P50 | author | Tao Ke | Q84029970 |
| P2093 | author name string | Wenbin Zhang | |
| Feng Zhao | |||
| Qun Yang | |||
| Yunlong Hu | |||
| Erik R Swenson | |||
| Jingyuan Chen | |||
| Jiye Wang | |||
| Mingchao Liu | |||
| Wenjing Luo | |||
| Xiangnan Zhang | |||
| Yaoming Chen | |||
| Xuefeng Shen | |||
| P2860 | cites work | Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans | Q46360057 |
| Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. | Q48374480 | ||
| Human pulmonary vascular response to 4 h of hypercapnia and hypocapnia measured using Doppler echocardiography. | Q51694130 | ||
| Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. | Q52073422 | ||
| Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. | Q52431887 | ||
| High-altitude illness | Q57109395 | ||
| Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema | Q57113288 | ||
| Hypoxia-induced ANP secretion in subjects susceptible to high-altitude pulmonary edema | Q57120651 | ||
| Estimation of pulmonary artery pressure by Doppler echocardiography in normal subjects made hypoxic | Q68597263 | ||
| Acetazolamide reduces hypoxic pulmonary vasoconstriction in isolated perfused rabbit lungs | Q74340435 | ||
| Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes | Q80576458 | ||
| Ginkgo biloba extract improves coronary artery circulation in patients with coronary artery disease: contribution of plasma nitric oxide and endothelin-1 | Q81186952 | ||
| Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial | Q82866936 | ||
| Acetazolamide: a treatment for chronic mountain sickness | Q28269409 | ||
| High-altitude pulmonary edema is initially caused by an increase in capillary pressure. | Q33943879 | ||
| Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor | Q34125858 | ||
| Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial | Q34192718 | ||
| Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. | Q34363422 | ||
| Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition. | Q34570393 | ||
| Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial | Q34570966 | ||
| Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness | Q34602544 | ||
| Acetazolamide-mediated decrease in strong ion difference accounts for the correction of metabolic alkalosis in critically ill patients | Q34999310 | ||
| Physiological aspects of high-altitude pulmonary edema | Q36036151 | ||
| High altitude-induced pulmonary oedema | Q36563681 | ||
| Ginkgo biloba extract prevents high altitude pulmonary edema in rats | Q38904922 | ||
| The action of hypercapnia during hypoxia on pulmonary vessels | Q39178469 | ||
| Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition | Q42506480 | ||
| Protective effect of ginkgo biloba extract on endothelial cell against damage induced by oxidative stress | Q44228710 | ||
| Inhibitors of hypoxic pulmonary vasoconstriction prevent high-altitude pulmonary edema in rats | Q44811816 | ||
| Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs | Q44973136 | ||
| Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. | Q45945641 | ||
| P433 | issue | 2 | |
| P921 | main subject | acetazolamide | Q413690 |
| P304 | page(s) | 162-167 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | High Altitude Medicine & Biology | Q13726582 |
| P1476 | title | Effect of acetazolamide and gingko biloba on the human pulmonary vascular response to an acute altitude ascent | |
| P478 | volume | 14 |
| Q52805051 | Carbonic anhydrase is not a relevant nitrite reductase or nitrous anhydrase in the lung. |
| Q58769834 | Ginkgo biloba extract for prevention of acute mountain sickness: a systematic review and meta-analysis of randomised controlled trials |
| Q38707663 | Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs |
| Q90224355 | Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions |
| Q38235629 | New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases |
| Q48252117 | Pharmacological interventions for preventing acute mountain sickness: a network meta-analysis and trial sequential analysis of randomized clinical trials |
| Q37679362 | Pulmonary vasodilation by acetazolamide during hypoxia: impact of methyl-group substitutions and administration route in conscious, spontaneously breathing dogs |
| Q40625240 | The noncarbonic anhydrase inhibiting acetazolamide analog N-methylacetazolamide reduces the hypercapnic, but not hypoxic, ventilatory response |
Search more.